Chlamydia pneumoniae causes a range of respiratory infections including bronchitis,
pharyngitis and pneumonia. Infection has also been implicated in exacerbation/initiation of …

Chlamydia pneumoniae is responsible for up to 20% of community acquired pneumonia and
can exacerbate chronic inflammatory diseases. As the majority of infections are either mild …

Chlamydia trachomatis is the most common bacterial sexually transmitted disease in the
world and specifically in the United States, with the highest incidence in age-groups 14–19 …

Groups of BALB/c mice were orally immunized with chlamydiae and challenged intranasally
to determine whether oral immunization offers protection against pulmonary disease and to …

We previously reported that DNA vaccination was able to elicit cellular immune responses
and partial protection against Chlamydia trachomatis infection. However, DNA immunization …

ABSTRACT BALB/c mice were vaccinated by the intramuscular (im) and subcutaneous (sc)
routes with a native preparation of the Chlamydia trachomatis mouse pneumonitis (MoPn) …

Chlamydia trachomatis causes respiratory and sexually transmitted infections. Here, we
tested a vaccine formulated with the recombinant major outer membrane protein from C …

Monoclonal antibodies (MAbs) to the Chlamydia trachomatis mouse pneumonitis (MoPn)
major outer membrane protein (MOMP) were characterized for their ability to neutralize the …

Recently, we have shown that a vaccine consisting of a purified preparation of the
Chlamydia trachomatis mouse pneumonitis (MoPn) major outer membrane protein (MOMP) …

Chlamydia pneumoniae is emerging as a significant human pathogen. Infection causes a
range of respiratory tract diseases and is associated with atherosclerosis. A vaccine could …